HIV-1 inhibitor-41 (Compound B23) is an orally active non-nucleoside HIV-1 reverse transcriptase inhibitor with EC50 values of 50 nM against the mutant E138K strain and 20.8 nM against HIV-1 WT. HIV-1 inhibitor-41 exhibits low hERG inhibition, no apparent CYP enzymatic inhibition, and no acute toxicity [1].
Molecular Weight:
335.37
Formula:
C16H15F2N3OS
Target:
Others|||Reverse Transcriptase|||HIV Protease
* VAT and and shipping costs not included. Errors and price changes excepted
